Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney

被引:66
作者
vanderGiet, M [1 ]
Khattab, M [1 ]
Borgel, J [1 ]
Schluter, H [1 ]
Zidek, W [1 ]
机构
[1] RUHR UNIV BOCHUM,MARIENHOSP HERNE,MED KLIN 1,D-44625 HERNE,GERMANY
关键词
purinoceptors; diadenosine phosphates; P-2-receptors; P-1-receptors; rat isolated perfused kidney; vasoconstriction; vasodilatation; PURINERGIC RECEPTORS; BLOOD-PRESSURE; RELEASE; POLYPHOSPHATES; ADENOSINE; RESPONSES; AP3A; AP4A;
D O I
10.1038/sj.bjp.0701074
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The activation of various purinoceptors in rat renal vasculature by P-1,P-2-diadenosine pyrophosphate (Ap(2)A), P-1,P-3-diadenosine triphosphate (Ap(3)A), P-1,P-4-diadenosine tetraphosphate (Ap(4)A), P-1,P-5-diadenosine pentaphosphate (Ap(5)A), P-1,P-6-diadenosine hexaphosphate (Ap(6)A) was studied by measuring their effects of perfusion pressure of a rat isolated perfused kidney. 2 The vasoconstrictive response to Ap(5)A was completely due to P-2X purinoceptor activation, that to Ap(4)A and Ap(6) was P-2X purinoceptor mediated to a large extent, as evidenced by the inhibitory effects of suramin and pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid tetrasodium (PPADS). 3 The vasoconstrictive effects of Ap(2)A and Ap(3)A were mostly due to stimulation of A(1)-receptors, as shown by the inhibitory effect of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). 4 The vasoconstrictive response to Ap(6)A was partially insensitive to A(1) and P-2X purinoceptor blockers. 5 In raised tone preparations Ap(2)A and Ap(3)A evoked vasodilatation, which was blocked by the A(2) receptor blocker, 3,7-dimethyl-1-propargylxanthine (DMPX). 6 In raised tone preparations Ap(4)A evoked vasodilatation when the P-2-purinoceptors were blocked by suramin. 7 The activation of different purinoceptor subtypes by diadenosine phosphates critically depends on the number of phosphate groups.
引用
收藏
页码:1453 / 1460
页数:8
相关论文
共 21 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   CONTRASTING EXCITATORY AND INHIBITORY EFFECTS OF ADENOSINE IN BLOOD-PRESSURE REGULATION [J].
BIAGGIONI, I .
HYPERTENSION, 1992, 20 (04) :457-465
[3]   STRUCTURE-ACTIVITY-RELATIONSHIPS FOR DERIVATIVES OF ADENOSINE-5'-TRIPHOSPHATE AS AGONISTS AT P-2 PURINOCEPTORS - HETEROGENEITY WITHIN P-2X AND P-2Y SUBTYPES [J].
BURNSTOCK, G ;
FISCHER, B ;
HOYLE, CHV ;
MAILLARD, M ;
ZIGANSHIN, AU ;
BRIZZOLARA, AL ;
VONISAKOVICS, A ;
BOYER, JL ;
HARDEN, TK ;
JACOBSON, KA .
DRUG DEVELOPMENT RESEARCH, 1994, 31 (03) :206-219
[4]   CELL-SPECIFIC PURINERGIC RECEPTORS COUPLED TO CA2+ ENTRY AND CA2+ RELEASE FROM INTERNAL STORES IN ADRENAL CHROMAFFIN CELLS - DIFFERENTIAL SENSITIVITY TO UTP AND SURAMIN [J].
CASTRO, E ;
MATEO, J ;
TOME, AR ;
BARBOSA, RM ;
TERESA, M ;
MIRASPORTUGAL, MT ;
ROSARIO, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5098-5106
[5]  
CHURCHILL PC, 1993, J PHARMACOL EXP THER, V265, P334
[6]   EFFECT OF DIADENOSINE PHOSPHATES ON HUMAN UMBILICAL VESSELS - NOVEL PLATELET-DERIVED VASOCONSTRICTORS [J].
DAVIES, G ;
MACALLISTER, RJ ;
BOGLE, RG ;
VALLANCE, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (02) :170-172
[7]   REGULATION OF RAT MESANGIAL CELL-GROWTH BY DIADENOSINE PHOSPHATES [J].
HEIDENREICH, S ;
TEPEL, M ;
SCHLUTER, H ;
HARRACH, B ;
ZIDEK, W .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2862-2867
[8]   CONVERSION OF ANGIOTENSIN-I INTO ANGIOTENSIN-II IN ISOLATED PERFUSED RAT-KIDNEY [J].
HOFBAUER, KG ;
ZSCHIEDRICH, H ;
RAUH, W ;
GROSS, F .
CLINICAL SCIENCE, 1973, 44 (05) :447-456
[9]   PHARMACOLOGICAL ACTIVITY OF ADENINE DINUCLEOTIDES IN THE PERIPHERY - POSSIBLE RECEPTOR CLASSES AND TRANSMITTER FUNCTION [J].
HOYLE, CHV .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1990, 21 (06) :827-831
[10]  
HOYLE CHV, 1992, INT J PURINE PYRIMID, V3, P13